These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 9647484

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
    Min JY, Sandmann S, Meissner A, Unger T, Simon R.
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
    [Abstract] [Full Text] [Related]

  • 5. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
    Sarsero D, Fujiwara T, Molenaar P, Angus JA.
    Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
    [Abstract] [Full Text] [Related]

  • 6. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
    Baylis C, Qiu C, Engels K.
    Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
    [Abstract] [Full Text] [Related]

  • 7. Role of sympathetic nerves in the differential effects of T-type and L-type calcium channel blockers on renin secretion and renin gene expression.
    Hinder M, Wagner C, Krämer BK, Kurtz A.
    Nephrol Dial Transplant; 1999 Dec; 14 Suppl 4():44-5. PubMed ID: 10463214
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.
    Ma G, Allen TJ, Cooper ME, Cao Z.
    Kidney Int; 2004 Sep; 66(3):1090-8. PubMed ID: 15327403
    [Abstract] [Full Text] [Related]

  • 11. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
    Major TC, Dhamija S, Black N, Liachenko S, Morenko B, Sobocinski G, Okerberg C, Tinholt P, Madore S, Kowala MC.
    J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2.
    Moosmang S, Haider N, Brüderl B, Welling A, Hofmann F.
    Circ Res; 2006 Jan 06; 98(1):105-10. PubMed ID: 16306443
    [Abstract] [Full Text] [Related]

  • 14. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A, Mathy MJ, Balt JC, Pfaffendorf M, van Zwieten PA.
    Fundam Clin Pharmacol; 2004 Jun 06; 18(3):309-19. PubMed ID: 15147282
    [Abstract] [Full Text] [Related]

  • 15. Structural changes and cyclic GMP content of the aorta after calcium antagonism or angiotensin converting enzyme inhibition in renovascular hypertensive rats.
    Véniant M, Gray GA, Heudes D, Ménard J, Clozel JP.
    J Hypertens; 1995 Jul 06; 13(7):731-7. PubMed ID: 7594436
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: comparison with amlodipine.
    Roux S, Bühler M, Clozel JP.
    J Cardiovasc Pharmacol; 1996 Jan 06; 27(1):132-9. PubMed ID: 8656647
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.